Evidence map›Paper›PMID 35173700›Full record

ArticleFrontiers in microbiology2022

Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant

Yu-Ping Wang, Yen-Hao Chen, I-Cheng Hung, Po-Hsun Chu, Yu-Han Chang, Yi-Tsung Lin, Hung-Chih Yang, Jin-Town Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Description of a chromosomalAntimicrobial agents and chemotherapy · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Fosfomycin-resistantJAC-antimicrobial resistance · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Polyclonal Multidrug ESBL-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Fosfomycin resistance mechanisms inFrontiers in cellular and infection microbiology · 2023
    Review
  13. Analysis of Risk Factors for Carbapenem ResistantInfection and drug resistance · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. An outbreak of extensively drug-resistant and hypervirulentFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yu-Ping WangDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Yen-Hao ChenDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
I-Cheng HungDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Po-Hsun ChuDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Yu-Han ChangDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Yi-Tsung LinDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hung-Chih YangDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Jin-Town WangDepartment of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
National Taiwan University · TWFu Jen Catholic University · TWNational Taiwan University Hospital · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections caused by carbapenem-resistant

Indexed as

carbapenem resistance enterobacteriaceaefosfomycin resistance genefosfomycin resistance mechanismglpT and uhpT transportersKlebsiella pneumoniae

Identifiers

PMID35173700
PMCPMC8841775
OpenAlexW4210429276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.